Literature DB >> 16386961

Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.

Erwan R W A N Piriou1, Karel van Dort, Jan F L Weel, Frederike J Bemelman, Laila E Gamadia, Marinus H J van Oers, Debbie van Baarle.   

Abstract

The etiology of infectious mononucleosis is poorly understood and usually detected many weeks after infection. Here, we present a unique case of primary symptomatic EBV infection after kidney transplantation, in whom we analyzed both EBV-specific CD4+ and CD8+ T cells in detail from the moment of infection up to latency. We show that EBV-specific T-cell responses in peripheral blood during primary EBV infection after kidney transplantation peaked early after the appearance of viral load, but well before onset of IM symptoms, suggesting that IM in this case is not caused by high numbers of CD8+ T cells per se but may be caused by lack of homing to lymph nodes or tonsils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16386961     DOI: 10.1016/j.clim.2005.11.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

1.  Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.

Authors:  J Scherrenburg; E R W A N Piriou; N M Nanlohy; D van Baarle
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

2.  Factors involved in the generation of memory CD8+ T cells in patients with X-linked lymphoproliferative disease (XLP).

Authors:  L Belmonte; C Parodi; P Baré; A Malbrán; B Ruibal-Ares; María M de E de Bracco
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.

Authors:  Heather M Long; Odette L Chagoury; Alison M Leese; Gordon B Ryan; Eddie James; Laura T Morton; Rachel J M Abbott; Shereen Sabbah; William Kwok; Alan B Rickinson
Journal:  J Exp Med       Date:  2013-04-08       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.